Back to all articles
Neutral +5

Tesla (TSLA) Stock Climbs as Chinese EV Deliveries Surge 36% Year-Over-Year in April

📈 Tesla's Shanghai facility delivered 79,478 units in April, marking a 36% year-over-year increase despite a sequential dip of 7.2% from March.

🚗 This performance extends the company's positive trajectory to six consecutive months of annual growth in both domestic Chinese sales and international shipments.

📉 Despite the stock rising 2.4% on trading news, Wall Street analysts maintain a "Hold" consensus with a mean price objective of $398.42.

⚠️ Tesla's Full Self-Driving (FSD) authorization rollout in China was pushed back to Q3 from the initial Q1 target during April earnings.

💰 CEO Elon Musk and CFO Vaibhav Taneja acknowledged the FSD delay, which impacts a key competitive advantage for affluent Chinese consumers.

🔋 Tesla is engineering a more affordable, compact SUV for local production in China to counter competition from budget-friendly local manufacturers.

📉 BYD, Tesla's main competitor in China, saw a 15% annual sales decline in April while delivering 314,100 units compared to Tesla's growth.

🇪🇺 Tesla observed improved demand in European territories like Sweden and France, partly driven by escalating petroleum prices due to geopolitical tensions.

📊 Q1 earnings per share reached $0.41, beating analyst estimates of $0.39, while quarterly revenue hit $22.39 billion, slightly missing the $22.96 billion consensus.

💸 Corporate insiders sold over 80,000 shares totaling approximately $30.8 million over the last three months, with board member Kathleen Wilson-Thompson reducing her stake by 35.3%.

📈 Institutional investor Gateway Investment Advisers increased its holdings by 0.5% in Q4, acquiring an additional 2,279 shares worth ~$10 million.

🤝 Analyst sentiment remains mixed with 19 Buy ratings versus 17 Hold and 5 Sell recommendations among the 41 firms covering TSLA.

📉 Truist Financial lowered its price objective to $400 while reaffirming a Hold rating, whereas Bank of America keeps a Buy stance with a $460 target.

🌍 China's overall new energy vehicle retail market grew 7% year-over-year to 1.22 million units in April, indicating broader market stabilization.

📉 Tesla faced dramatic erosion of its European market position in 2025, surrendering nearly half its share due to competition from affordable Chinese EVs.

Bullish Signals
  • Tesla's Shanghai manufacturing operations achieved a robust 36% year-over-year increase in April deliveries, reaching 79,478 units.
  • The company has now recorded six consecutive months of positive year-over-year growth in its Chinese operations and global exports.
  • Tesla's first quarter earnings per share of $0.41 exceeded analyst expectations of $0.39, demonstrating strong profitability despite missing revenue targets.
  • Quarterly revenue reached $22.39 billion with a significant 15.8% year-over-year expansion, highlighting resilient top-line performance.
  • In the Chinese market, competitor BYD experienced a 15% annual sales decline while Tesla maintained steady growth, indicating potential market share gains.
  • European markets showed strong demand recovery, with Sweden, France, and Denmark recording particularly strong upticks in sales during April.
  • Tesla successfully navigated high petroleum prices linked to geopolitical tensions to bolster its electric vehicle demand in Europe.
  • Institutional investor confidence persists as Gateway Investment Advisers increased its Tesla holdings by 0.5% to a total value of $224.3 million.
  • Market sentiment remains positive with 19 out of 41 analysts maintaining Buy recommendations, including Bank of America's $460 price target.
Risk Factors
  • The timeline for Full Self-Driving (FSD) authorization in China has been pushed back to Q3 from the initially projected Q1, delaying a crucial competitive advantage in the region.
  • Tesla's Chinese operations face significant headwinds from intensified competition against more affordable domestic manufacturers, which previously caused Tesla to lose nearly half its European market share in 2025.
  • Company insiders collectively sold over 80,000 shares worth approximately $30.8 million in the last three months, signaling a lack of confidence among corporate leadership.
  • Tesla's Q1 revenue of $22.39 billion fell marginally short of the $22.96 billion consensus projection despite exceeding earnings per share expectations.
  • BYD, Tesla's principal competitor in China, recently experienced a 15% annual sales decline in April while maintaining dominance against Tesla's market position.
  • The stock currently trades at a mean analyst price target of $398.42, with a general consensus rating of 'Hold' rather than a strong Buy.
  • Truist Financial specifically reduced its price objective from $438 to $400 on April 2, citing continued concerns over valuation and competitive pressures.
Full Analysis
Tesla's stock price rose as the company reported April deliveries from its Shanghai factory reached 79,478 units, a 36% increase compared to last year and marking six consecutive months of annual growth. This performance came despite a sequential dip of 7.2% from March's figures of 85,670 units. Analysts noted that while deliveries declined slightly month-over-month, the robust year-over-year trajectory in China suggests market stabilization after challenges faced throughout 2024 and early 2025. However, optimism was tempered by several setbacks. The rollout of Full Self-Driving technology in China has been postponed to the third quarter from the initial first-quarter target, a delay acknowledged by CFO Vaibhav Taneja during the April earnings call. Additionally, Tesla faces intensified competition in both China and Europe; while Tesla improved its European market share in Sweden, France, and Denmark due partly to high gasoline prices linked to geopolitical tensions, it previously lost nearly half of its European market position in 2025. Financially, the company reported first-quarter earnings per share of $0.41, beating expectations of $0.39, though revenue of $22.39 billion missed analyst projections of $22.96 billion. Insiders showed significant selling pressure with over 80,000 shares sold in three months worth about $30.8 million, including a notable sale by Board member Kathleen Wilson-Thompson who reduced her stake by 35.3%. Wall Street consensus remains mixed with a mean price objective of $398.42 and a "Hold" rating, though analysts are split with 19 Buy recommendations against 5 Sells.